Metoclopramide high-dose

Drug Profile

Metoclopramide high-dose

Alternative Names: Sensamide

Latest Information Update: 11 Jun 2002

Price : $50

At a glance

  • Originator OXiGENE
  • Class Aminobenzoic acids; Antiemetics; Antineoplastics; Benzamides; Chlorobenzenes; Diethylamines; Gastrokinetics; Phenyl ethers; Radiation-sensitising agents; Radiosensitisers; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Non-small cell lung cancer; Squamous cell cancer

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 11 Jun 2002 Discontinued - Phase-III for Non-small cell lung cancer in European Union (unspecified route)
  • 11 Jun 2002 Discontinued - Phase-III for Squamous cell cancer in European Union (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top